3 NEWS #usa Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide - CNBC
- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide CNBC
- Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market Yahoo Finance
- Amgen goes all in on injectable obesity drug as it scraps early-stage pill STAT
- Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug. Barron's
- Novo Slides as Amgen Fuels Obesity Drug Competition Fears Bloomberg








Publicar un comentario